Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
Lucie Bernard, Mericien Venzon, Jon Klein, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

A review of cytokine-based pathophysiology of Long COVID symptoms
Russell N. Low, Ryan Low, Athena Akrami
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 101
Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders
Janet M. Sasso, Ramy M. Ammar, Rumiana Tenchov, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1717-1763
Open Access | Times Cited: 97
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 80
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
Giuseppe Ancona, Laura Alagna, Claudia Alteri, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Farzaneh Fakharian, Siva Thirugnanam, David A. Welsh, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1849-1849
Open Access | Times Cited: 43
The gut–airway microbiome axis in health and respiratory diseases
Mustafa Özçam, Susan V. Lynch
Nature Reviews Microbiology (2024) Vol. 22, Iss. 8, pp. 492-506
Closed Access | Times Cited: 25
Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair
Veronica Marrella, Federico Nicchiotti, Barbara Cassani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4051-4051
Open Access | Times Cited: 19
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Shuaiqi Wang, Dianwen Ju, Xian Zeng
Biomedicines (2024) Vol. 12, Iss. 1, pp. 194-194
Open Access | Times Cited: 16
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond
Anthony R. Sciaudone, Heather A. Corkrey, Fiachra Humphries, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1272-1289
Open Access | Times Cited: 39
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms
Viviani Mendes de Almeida, Daiane F. Engel, Mayra Fernanda Ricci, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 38
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 36
Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification
Carlo Brogna, Vincenzo Costanzo, Barbara Brogna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3929-3929
Open Access | Times Cited: 25
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Vaibhav Upadhyay, Rahul K. Suryawanshi, Preston Tasoff, et al.
mBio (2023)
Open Access | Times Cited: 25
COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens
Sterlin T. Raj, Alexander W. Bruce, Muralidharan Anbalagan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness
Nicole A. Cho, Kathryn Strayer, Breenna Dobson, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Longitudinal multicompartment characterization of host-microbiota interactions in patients with acute respiratory failure
Georgios D. Kitsios, Khaled Sayed, Adam Fitch, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Interaction between intestinal mycobiota and microbiota shapes lung inflammation
Youxia Wang, Fang He, Bingnan Liu, et al.
iMeta (2024) Vol. 3, Iss. 5
Open Access | Times Cited: 9
Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study
Miao Cai, Evan Xu, Yan Xie, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Role of Microbiota in Viral Infections and Pathological Progression
Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 950-950
Open Access | Times Cited: 35
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
Virna Margarita Martín Giménez, Javier Modrego, Dulcenombre Gómez‐Garré, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12249-12249
Open Access | Times Cited: 21
Robust cross-cohort gut microbiome associations with COVID-19 severity
Junhui Li, Tarini Shankar Ghosh, Rachel MacCann, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation
Juan Pacheco‐Yanes, Eric C. Reynolds, Jian Li, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 11, pp. 912-925
Closed Access | Times Cited: 20
Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management
Tao Han Lee, Jia‐Jin Chen, Chao‐Yi Wu, et al.
Biomedical Journal (2023) Vol. 47, Iss. 2, pp. 100638-100638
Open Access | Times Cited: 19
Gut microbiota in COVID-19: new insights from inside
Bingqian Zhou, Xiaoqi Pang, Jingyi Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top